Androgen receptor

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

(Redirected from Androgen receptors)
Jump to: navigation, search

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.


Androgen receptor (dihydrotestosterone receptor; testicular feminization; spinal and bulbar muscular atrophy; Kennedy disease)
PDB rendering based on 2AM9.
Identifiers
Symbol(s) AR; AIS; DHTR; HUMARA; KD; NR3C4; SBMA; SMAX1; TFM
External IDs OMIM: 313700 MGI88064 Homologene28
RNA expression pattern

More reference expression data

Orthologs
Human Mouse
Entrez 367 11835
Ensembl ENSG00000169083 ENSMUSG00000046532
Uniprot P10275 P19091
Refseq NM_000044 (mRNA)
NP_000035 (protein)
NM_013476 (mRNA)
NP_038504 (protein)
Location Chr X: 66.68 - 66.87 Mb Chr X: 94.35 - 94.52 Mb
Pubmed search [2] [3]

WikiDoc Resources for

Androgen receptor

Articles

Most recent articles on Androgen receptor

Most cited articles on Androgen receptor

Review articles on Androgen receptor

Articles on Androgen receptor in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Androgen receptor

Images of Androgen receptor

Photos of Androgen receptor

Podcasts & MP3s on Androgen receptor

Videos on Androgen receptor

Evidence Based Medicine

Cochrane Collaboration on Androgen receptor

Bandolier on Androgen receptor

TRIP on Androgen receptor

Clinical Trials

Ongoing Trials on Androgen receptor at Clinical Trials.gov

Trial results on Androgen receptor

Clinical Trials on Androgen receptor at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Androgen receptor

NICE Guidance on Androgen receptor

NHS PRODIGY Guidance

FDA on Androgen receptor

CDC on Androgen receptor

Books

Books on Androgen receptor

News

Androgen receptor in the news

Be alerted to news on Androgen receptor

News trends on Androgen receptor

Commentary

Blogs on Androgen receptor

Definitions

Definitions of Androgen receptor

Patient Resources / Community

Patient resources on Androgen receptor

Discussion groups on Androgen receptor

Patient Handouts on Androgen receptor

Directions to Hospitals Treating Androgen receptor

Risk calculators and risk factors for Androgen receptor

Healthcare Provider Resources

Symptoms of Androgen receptor

Causes & Risk Factors for Androgen receptor

Diagnostic studies for Androgen receptor

Treatment of Androgen receptor

Continuing Medical Education (CME)

CME Programs on Androgen receptor

International

Androgen receptor en Espanol

Androgen receptor en Francais

Businness

Androgen receptor in the Marketplace

Patents on Androgen receptor

Experimental / Informatics

List of terms related to Androgen receptor

The androgen receptor (AR), also known as NR3C4 (nuclear receptor subfamily 3, group C, member 4), is a type of nuclear receptor which is activated by binding of either of the androgenic hormones testosterone or dihydrotestosterone.[1] The main function of the androgen receptor is as a DNA binding transcription factor which regulates gene expression.[1] However the androgen receptor also has additional functions independent of DNA binding[1]

The androgen receptor is most closely related to the progesterone receptor, and progestins in higher dosages can block the androgen receptor.

Structure

Two isoforms of the androgen receptor (A and B) have been identified:[1]

  • AR-A - 87 kDa - N-terminus truncated (lacks the first 187 amino acids)
  • AR-B - 110 kDa - full length

Domains

Like other nuclear receptors, the androgen receptor is modular in structure and is comprised of the following functional domains labeled A through F:

  • A/B) - N-terminal regulatory domain contains:[1]
    • activation function 1 (AF-1) between residues 101 and 370 required for full ligand activated transcriptional activity
    • activation function 5 (AF-5) between residues 360-485 is responsible for the constitutively activity (activity without bound ligand)
    • dimerization surface involving residues 1-36 (containing the FXXLF motif where F = phenylalanine, L = leucine, and X = any amino acid residue) and 370-494 which both interact with the LBD in an unusual (for a nuclear receptor) head-to-tail interaction[1][1][1]
  • C) - DNA binding domain (DBD)
  • D) - Hinge region - flexible region that connects the DBD with the LBD; influences subcellular trafficking
  • E) - Ligand binding domain (LBD) containing
    • activation function 2 (AF-2), responsible for agonist induced activity (activity in the presence of bound agonist)
    • AF-2 binds both coactivator proteins (containing the LXXLL motif) and/or the AF-1 region of another molecule of androgen receptor (containing the FXXLF motif) to form a head-to-tail dimer[1]
  • F) - C-terminal domain

Gene

The AR gene for the androgen receptor is located on the X chromosome at Xq11-12.

Function

Genomic

In some cell types testosterone interacts directly with androgen receptors while in others testosterone is converted by 5-alpha-reductase to dihydrotestosterone, an even more potent agonist for androgen receptor activation. Testosterone appears to be the primary androgen receptor activating hormone in the Wolffian duct while dihydrotestosterone is the main androgenic hormone in the urogenital sinus, urogenital tubercle, and hair follicles.

The primary mechanism of action for androgen receptors is direct regulation of gene transcription. The binding of an androgen to the androgen receptor results in a conformational change in the receptor which in turn causes dissociation of heat shock proteins, dimerization, and transport from the cytosol to the cell nucleus where the androgen receptor dimer binds to a specific sequence of DNA known as a hormone response element. Androgen receptors interact with other proteins in the nucleus resulting in up or down regulation of specific gene transcription. Up-regulation or activation of transcription results in increased synthesis of messenger RNA which in turn is transcribed by ribosomes to produce specific proteins. One of the known target genes of androgen receptor activation is insulin-like growth factor I (IGF-1). Thus, changes in levels of specific proteins in cells is one way that androgen receptors control cell behavior.

Androgens cause slow epiphysis, or maturation of the bones, but more of the potent epiphysis effect comes from the estrogen produced by aromatization of androgens. Steroid users of teen age may find that their growth had been stunted by androgen and/or estrogen excess. People with too little sex hormones can be short during puberty but end up taller as adults as in androgen insensitivity syndrome or estrogen insensitivity syndrome.

Non-genomic

More recently, androgen receptors have been shown to have a second mode of action. As has been also found for other steroid hormone receptors such as estrogen receptors, androgen receptors can have actions that are independent of their interactions with DNA.[1][1] Androgen receptors interact with certain signal transduction proteins in the cytoplasm. Androgen binding to cytoplasmic androgen receptors can cause rapid changes in cell function independent of changes in gene transcription, such as changes in ion transport. Regulation of signal transduction pathways by cytoplasmic androgen receptors can indirectly lead to changes in gene transcription, for example, by leading to phosphorylation of other transcription factors.

One function of androgen receptor that is independent of direct binding to its target DNA sequence, is facilitated by recruitment via other DNA binding proteins. One example is Serum Response Factor, a protein which activates several genes that cause muscle growth.[1]

AR deficiencies

The androgen insensitivity syndrome, formerly known as testicular feminization, is caused by a mutation of the Androgen Receptor gene located on the X chromosome (locus:Xq11-Xq12). The androgen receptor seems to affect neuron physiology and is defective in Kennedy disease.

References

See also

External links

fr:récepteur des androgènes
WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch


Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

Views